United States Hepatitis B Vaccine Market Growth Driven by Immunization Programs and Rising Disease Prevalence | Key Players: Merck & Co., Inc, Sanofi, GlaxoSmithKline plc, Indian Immunologicals Limited, LG Chem

The Global Hepatitis B Vaccine Market reached USD 4.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 6.1 billion by 2030. The global hepatitis B vaccine market is expected to exhibit a CAGR of 4.6% during the forecast period (2023-2030).

The most recent report published by DataM Intelligence indicates that the "Hepatitis B Vaccine Market" is likely to accelerate significantly in the next few years. The Hepatitis B Vaccine Market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The Hepatitis B Vaccine Market study includes information on market factors such as the market dynamics, drivers, restraints, challenges, threats, potential growth opportunities, market trends, development patterns, financial information, latest technologies, innovations, leading competitors, and regional analysis of the market.

Hepatitis B vaccines protect against HBV infection and are used in infant immunization programs, prenatal screening pathways, and high-risk adult groups. The vaccine market is stable but sees renewed interest from efforts to increase coverage and develop next-generation or therapeutic HBV vaccines. In the U.S., recent focus includes expanded screening and vaccination outreach, public-health funding for catch-up immunizations, and support for trials of improved or therapeutic vaccine candidates as part of broader hepatitis-elimination goals.

Download Latest Sample of This Strategic Report@ https://www.datamintelligence.com/download-sample/hepatitis-b-vaccine-market?ophp

The list of Key Players Profiled in the study includes:- Merck & Co., Inc, Sanofi, GlaxoSmithKline plc, Indian Immunologicals Limited, LG Chem, KM Biologics, Dynavax Technologies, Bharat Biotech, Serum Institute of India Pvt. Ltd, and Biological E Limited among others.

United States: Recent Hepatitis B Vaccine Developments

📌 In May 2025, Dynavax reported $65 million in first-quarter revenue for HEPLISAV-B, its adult adjuvanted hepatitis B vaccine, with a ~36% YoY growth. Its market share in the U.S. adult HBV vaccine segment rose to ~43%.

📌 In August 2025, Dynavax posted $92 million in second-quarter 2025 net product revenue for HEPLISAV-B, marking a 31% increase vs. the same quarter in 2024, while its U.S. adult hepatitis B vaccine market share increased to ~45%.

📌 In July 2025, market forecasts continued to point toward strong growth: the global hepatitis B vaccine market was projected to exceed USD 12 billion by 2034, driven by expanded immunization programs, improved vaccine technologies, and growing demand for adult vaccination.

Competitive Analysis:

The Hepatitis B Vaccine Market is expected to grow significantly over the forecast period between 2025 and 2032. In 2025, the Hepatitis B Vaccine Market will grow steadily, and with the increasing adoption of strategies by the major players; the research study is expected to rise above the forecast horizon. The competitive analysis focuses on key players and the innovations and business strategies undertaken by them. The report captures the best long-term growth opportunities for the industry and includes the latest process and product developments.

Market Dynamics:

✅Driver: Rising global vaccination programs and WHO initiatives drive hepatitis B vaccine demand.
✅Restraints: Limited awareness and accessibility in low-income regions restrict adoption.
✅Opportunities: Development of combination vaccines and pediatric immunization expansion offer growth opportunities.
✅Challenges: Cold-chain storage and vaccine hesitancy remain persistent hurdles.

Segmentation Analysis of the Market:

Global Hepatitis B Vaccine Market forecast report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market. Hepatitis B Vaccine Market, By Type (Combination Vaccines, Single Antigen Vaccine), By End-User (Hospitals, Clinics, Vaccination Centre, Others)

Research Methodology:

- Primary Research: This method involves collecting new and original data for a specific purpose. Primary research is often conducted through surveys, interviews, focus groups, and observation. It enables researchers to obtain first-hand information directly from the target audience, which is especially useful when researching a new or emerging market.

- Secondary Research: This method involves analyzing and synthesizing existing data from various sources such as industry reports, government publications, academic research, and online databases. Secondary research can provide researchers with valuable insights into industry trends, consumer behavior, and Hepatitis B Vaccine market size and growth, without the need for extensive data collection.

Most research studies use a combination of both primary and secondary research methods to ensure comprehensive and accurate data analysis. The specific methodology used in a Hepatitis B Vaccine market research study will depend on various factors such as the research objectives, the target audience, and the available resources.

Request Customized Market Entry Assessment for North America, EU, APAC: https://www.datamintelligence.com/customize/hepatitis-b-vaccine-market?ophp

Regional Outlook:

The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)

South America (Brazil, Argentina, Rest of SA)

Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

The analysis objectives of the report are:

- To determine the size of the Global Hepatitis B Vaccine Market by identifying its sub-segments.

- To research the key players and analyze their growth strategies.

- To assess the size and value of the Global Hepatitis B Vaccine Market based on key regions.

- To analyze the Global Hepatitis B Vaccine Market in terms of growth trends, potential, and participation in the overall sector.

- To investigate the Global Hepatitis B Vaccine Market size (volume and value) from the company, key regions/countries, goods and applications, and background data.

- Primary Global Hepatitis B Vaccine Market manufacturers to specify, clarify, and analyze the product sales volume, value, and market share, market rivalry landscape, SWOT analysis, and future development plans.

- To investigate market competitive developments such as market expansions, agreements, new product launches, and acquisitions.

Reasons to buy:

- Hepatitis B Vaccine Market Report segments the market based on economic and non-economic aspects and offers a qualitative and quantitative analysis of the market.

- Market value information is provided for each segment and sub-segment in the Hepatitis B Vaccine Market study.

- The region and market segment identified in this study are those predicted to expand the fastest and account for the majority of market shar

- The Hepatitis B Vaccine Market Analysis by Geography emphasizes the product or service's consumption in the area and identifies the market-affecting variables for each region.

- The major players' market rankings, as well as the recent partnerships, service/product launches, business expansions, and acquisitions of the companies profiled, are all included in the competitive landscape.

- Extensive company profiles for the top market players, including business overview, company insights, product benchmarking, and SWOT analysis.

- The industry's present and upcoming market outlook in consideration of recent changes, including growth possibilities and drivers as well as obstacles and restrictions in both developing and emerging regions.

- The Hepatitis B Vaccine Market offers comprehensive market analysis from a variety of angles using Porter's five forces analysis, as well as market insight using the Value Chain.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=hepatitis-b-vaccine-market

The report answers a number of crucial questions, including:

- Which companies dominate the global Hepatitis B Vaccine market?

- What current trends will influence the market over the next few years?

- What are the market's opportunities, obstacles, and driving forces?

- What predictions for the future can help with strategic decision-making?

- What advantages does market research offer businesses?

Get Corporate Access to Live Hepatitis B Vaccine Industry Intelligence Database: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.